NCT03280173View on ClinicalTrials.gov

A Study Comparing the Amounts of 2 Different Forms of Tafamidis (PF06291826), Both With and Without Food, In the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 29, 2017

Primary Completion Date

February 23, 2018

Study Completion Date

February 23, 2018

Conditions
Healthy
Interventions
DRUG

tafamidis

bioavailability study

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03280173 - A Study Comparing the Amounts of 2 Different Forms of Tafamidis (PF06291826), Both With and Without Food, In the Blood | Biotech Hunter | Biotech Hunter